Anna combines a background in Molecular Biology with experience in life science consulting. She completed her PhD in cancer research at the Research Center for Molecular Medicine (CeMM) in Vienna before joining the Boston Consulting Group (BCG) in Zürich. In this role, she supported major pharma companies on topics including supply chain setup, evidence planning strategies, and the redesign of business development organizations. At the Translational Medicine Accelerator, Anna is excited to help bridge academic science and industry by combining her foundation in biomedical research with her perspective on the pharma industry.